Sun Pharmaceutical Industries Share Price Today - Live Blog for April 08, 2025

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.09%, with its current market value per share resting at ₹1,688.40. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,689.60. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,692.30, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.03%, a development that warrants careful analysis. Presently trading at ₹1,694.90, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.35% slump and is currently trading at ₹1,693.00. While the stock maintains a PE ratio of 35.0100, the industry PE is 33.0184, raising questions about valuation.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.35% increase and currently trading at ₹1,691.75 per share. This upward trajectory is turning heads in the market.

With a -0.27% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,685.00. The stock is currently trading at a PE of 35.0100, while the industry PE is 33.0184, prompting investors to assess its value proposition.

After a -0.51% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,694.35. The stock has a PE ratio of 35.0100, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.51%, signalling a challenging period. Currently trading at ₹1,694.35, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.10% recently. As of now, this stock is actively trading at a current market price of ₹1,703.25 per share, attracting attention from investors.

Following a noteworthy 0.03% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,703.15. When it comes to valuation, this stock has a PE ratio of 35.0100, with the industry PE ratio at 33.0184.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,705.00 per share, making it an attractive option for investors.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.44% increase and currently trading at ₹1,702.95 per share. This upward trajectory is turning heads in the market.

With a remarkable 0.44% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,702.95. Notably, this stock has a Price-to-Earnings (PE) ratio of 35.0100, while the industry's PE ratio is 33.0184.

Sun Pharmaceutical Industries Ltd's share price has experienced a notable 0.44% upswing, and it's currently trading at ₹1,702.95 per share. Investors are closely watching this development.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.16% gain, with the share price now at ₹1,696.05. Notably, the stock's PE ratio stands at 35.0100, and its Return on Equity (ROE) is 15.9938%.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.04% increase and currently trading at ₹1,686.00 per share. This upward trajectory is turning heads in the market.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.04% increase and currently trading at ₹1,686.00 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.23% increase and currently trading at ₹1,686.70 per share. This upward trajectory is turning heads in the market.

Sun Pharmaceutical Industries Ltd experienced a -0.50% downturn in its share price, and it's currently trading at ₹1,682.10. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.39%, and as of now, it's trading at ₹1,680.55 per share. This upward trajectory is attracting keen interest from investors.

With a remarkable 0.39% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,680.55. Notably, this stock has a Price-to-Earnings (PE) ratio of 35.0100, while the industry's PE ratio is 33.0184.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.53%, signalling a challenging period. Currently trading at ₹1,674.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,682.05. This situation is generating interest among value investors who are evaluating the stock's potential.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.29%, reaching the current market price of ₹1,682.00. This ascent signifies increased investor sentiment. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.00%, reaching the current market price of ₹1,678.85. This development underscores the stock's growing popularity.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.39%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,679.95, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd share price has declined by -0.79%, and it's currently trading at ₹1,684.65. The stock maintains a PE of 35.0100, while the industry PE is 33.0184, prompting discussions about its valuation.